Public Roadmap
Von €281k zu €228M ARR
Transparenter Einblick in unsere Revenue-Strategie und Meilensteine
Q1 2026
€290k
ARR Target
Q2 2026
€2.5M
ARR Target
Q3 2026
€18M
ARR Target
Q4 2026
€36M
ARR Target
Q1 2026
Phase: Foundation • Target: €290k ARR
In Progress
Second Opinion Marketplace (MVP)
KI + Experten-Zweitmeinung für komplexe Fälle
Progress3/5
Frontend Development
Doctor Dashboard
Stripe Integration
Pilot mit 10 Ärzten
Beta Launch (100 Patienten)
Target Revenue
€30k ARR
CME Certification System
Ärztekammer-akkreditierte Fortbildungen
Progress0/4
Akkreditierungs-Prozess
Course Builder
Zertifikats-System
First 5 Kurse online
Target Revenue
€60k ARR
Precision Medicine API (Beta)
2 Pharma-Partner für genetische Daten
Progress0/4
API Development
Data Anonymization
Pharma Partner #1
First Dataset Sale
Target Revenue
€200k ARR
Revenue Target
€290k ARR
User Target
20,000
Key Hires
Head of Growth, Content Manager
Q2 2026
Phase: Scale • Target: €2.47M ARR
Planned
Global Expert Network
50 Rare Disease Experts weltweit
Progress0/4
Expert Recruitment
Video Consultation System
Quality Assurance Process
100 Consultations/Monat
Target Revenue
€180k ARR
Clinical Trial Recruitment (Pilot)
Erste 5 Pharma-Trials
Progress0/4
CRO-Partnerships
AI Matching Algorithm
First Trial: 50 Patients
Proof of 40% Qualify Rate
Target Revenue
€2M ARR
Outcome Tracking System
Basis für Hospital Partnerships
Progress0/4
Analytics Backend
Hospital Integration
Pilot mit 2 Kliniken
First ROI Proof
Target Revenue
€0 (Investment)
Revenue Target
€2.47M ARR
User Target
35,000
Key Hires
Head of Sales, 2 AEs, CSM
Q3 2026
Phase: Enterprise • Target: €18M ARR
Planned
Clinical Trials Skalierung
20 aktive Trials
Progress0/4
10 neue Pharma-Partner
500 Patients enrolled/Monat
Expansion: US + Asia
CRO-Zertifizierung
Target Revenue
€10M ARR
Krankenkassen-Partnerships
Erste 2 Piloten
Progress0/4
Predictive Model Development
Insurance Partner #1
1.000 prevented cases
Outcome Measurement
Target Revenue
€5M ARR
Outcome-Based Hospital Deals
3 Universitätskliniken
Progress0/4
Hospital Partner #1
6-Month Baseline
First Success Story
Case Study Publication
Target Revenue
€3M ARR
Revenue Target
€18M ARR
User Target
50,000
Key Hires
VP Sales, Partnerships Manager, Dev Advocate
Q4 2026
Phase: Dominance • Target: €36M ARR
Planned
50+ Clinical Trials Active
Market Leader in Trial Recruitment
Progress0/4
30 neue Trials
2.000 Patients enrolled/Monat
Global Expansion complete
Proprietary Database: 100k+ Patients
Target Revenue
€20M ARR
5 Krankenkassen-Verträge
Prevention at Scale
Progress0/4
3 neue Kassen
10.000 prevented cases
National Media Coverage
Government Approval
Target Revenue
€15M ARR
100+ CME-Kurse
Leading CME Platform
Progress0/4
50 neue Kurse
10.000 Ärzte aktiv
Multi-Specialty Coverage
International Accreditation
Target Revenue
€1M ARR
Revenue Target
€36M ARR
User Target
75,000
Key Hires
VP Product, Data Analyst, 5 Sales Reps
Bereit, Teil der Revolution zu werden?
Investoren, Partner, Kunden - wir suchen Visionäre, die das Gesundheitswesen transformieren wollen.